Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Sample Prep Startup Inso Biosciences Raises $2.2M in Pre-Seed Financing

NEW YORK – Inso Biosciences, a startup developing sample preparation methods for high-molecular weight DNA for long-read sequencing, has raised $2.2 million in pre-seed financing.

VC firm 2048 Ventures led the round, joined by SOSV, Whitecap Venture Partners, Ataraxia Ventures, and CRCM Ventures.

In a statement, the firm said it plans to use the funding to develop a benchtop instrument to automate DNA extraction, purification, fragmentation, and sizing.

Inso Cofounder Harold Craighead, a professor emeritus at Cornell University, also cofounded the company that became Pacific Biosciences.

The company said it has now raised a total of $2.8 in financing and grants.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.